SEARCH

SEARCH BY CITATION

References

  • Adab N, Jacoby A, Smith D, Chadwick D. (2001) Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70:1521.
  • Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, Coyle H, Fryer A, Gorry J, Gregg J, Mawer G, Nicolaides P, Pickering L, Tunnicliffe L, Chadwick DW. (2004) The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75:15751583.
  • Arpino C, Brescianini S, Robert E, Castilla E, Cocchi G, Cornel MC, DeVigan C, Lancaster PA, Merlob P, Sumiyoshi Y, Zampino G, Renzi C, Rosano A, Mastroiacovo P. (2000) Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). Epilepsia 41:14361443.
  • Artama M, Auvinen A, Raudaskoski T, Isojarvi I, Isojarvi J. (2005) Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64:18741878.
  • Bardy AH, Hiilesmaa VK, Teramo KA. (1987) Serum phenytoin during pregnancy, labor and puerperium. Acta Neurol Scand 75:374375.
  • Barrett C, Richens A. (2003) Epilepsy and pregnancy: report of an Epilepsy Research Foundation Workshop. Epilepsy Res 52:147187.
  • Battino D, Binelli S, Bossi L, Como ML, Croci D, Cusi C, Avanzini G. (1984) Changes in primidone/phenobarbitone ratio during pregnancy and the puerperium. Clin Pharmacokinet 9:252260.
  • Battino D, Binelli S, Bossi L, Canger R, Croci D, Cusi C, De Giambattista M, Avanzini G. (1985) Plasma concentrations of carbamazepine and carbamazepine 10,11-epoxide during pregnancy and after delivery. Clin Pharmacokinet 10:279284.
  • Bertollini R, Mastroiacovo P, Segni G. (1985) Maternal epilepsy and birth defects: a case–control study in the Italian Multicentric Registry of Birth Defects (IPIMC). Eur J Epidemiol 1:6772.
  • Bossi L, Assael BM, Avanzini G, Battino D, Caccamo ML, Canger R, Como ML, Pifarotti G, DeGiambattists M, Franceschetti S, Marini A, Pardi G, Porro MG, Rovei V, Sanjuan M, Soffientini ME, Spina S, Spreafico R. (1980) Plasma levels and clinical effects of antiepileptic drugs in pregnant epileptic patients and their newborns. Obstet Gynecol Surv 35:561562.
  • Canger R, Battino D, Canerini MP, Fumarola C, Guidolin L, Vignoli A, Mamoli D, Palmieri C, Molteni F, Granata T, Hassibi P, Zamperini P, Pardi G, Avanzini G. (1999) Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 40:12311236.
  • Cantrell D. (1997) Epilepsy and pregnancy: a study of seizure frequency and patient demographics. Epilepsia 38(Suppl. 8):231.
  • Chen S, Perucca E, Lee JN, Richens A. (1982) Serum protein binding and free concentration of phenytoin and phenobarbitone in pregnancy. Br J Clin Pharmacol 13:547552.
  • Christensen J, Sabers A, Sidenius P. (2006) Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy. Neurology 67:14971499.
  • Crawford P, Hudson S. (2003) Understanding the information needs of women with epilepsy at different lifestages: results of the ‘Ideal World’ survey. Seizure 12:502507.
  • Cunnington M, Ferber S, Quartey G. (2007) Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 48:12071210.
  • Dansky L, Andermann E, Sherwin AL, Andermann F. (1982) Plasma levels of phenytoin during pregnancy and the puerperium. In JanzD, DamM, RichensA, BossiL, HelgeH, SchmidtD (Eds). Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 155162.
  • Dean J, Hailey H, Moore S, Lloyd D, Turnpenn P, Little J. (2002) Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 39:251259.
  • Devinsky O, Yerby M. (1994) Women with epilepsy. Neurol Clin 12:479495.
  • Dickinson RG, Hooper WD, Wood B, Lander CM, Eadie MJ. (1989) The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin. Br J Clin Pharmacol 28:1727.
  • Dravet C, Julia C, Legras C, Magaudda A, Guerrini R, Genton P, Soulayrol S, Giraud N, Mesdjian E, Trentin G. (1992) Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 42(4 Suppl. 5):7582.
  • Ehmer U, Vogel A, Schutte JK, Krone B, Manns MP, Strassburg CP. (2004) Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 39:970977.
  • Fairgrieve SD, Jackson M, Jonas P, Walshaw D, White K, Montgomery TL, Burn J, Lynch SA. (2000) Population based, prospective study of the care of women with epilepsy in pregnancy. Br Med J 321:674675.
  • Gaily E, Kantola-Sorsa E, Hiilesmaa V, Isoaho M, Matila R, Kotila M, Nylund T, Bardy A, Kaaja E, Granstrom ML. (2004) Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62:2832.
  • Gee K, McCaule L, Lan N. (1995) A putative receptor for neurosteroids on the GABA receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol 9:207227.
  • Granstrom M, Gaily E. (1992) Psychomotor development in children of mothers with epilepsy. Neurology 42(Suppl. 5):144148.
  • De Haan GJ, Edelbroek P, Segers J, Engelsman M, Lindhout D, Devile-Notschaele M, Augustijn P. (2004) Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 63:571573.
  • Hernandez-Diaz S, Werler M, Walker A. (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med, 343:16081614.
  • Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. (2001) Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 153:961968.
  • Hernandez-Diaz S, Smith CR, Wyszynski DF, Holmes LB. (2007) Risk of major malformations among infants exposed to carbamazepine during pregnancy. Birth Defects Res A Clin Mol Teratol 79:357.
  • Holmes LB, Rosenberger PB, Harvey EA, Khoshbin S, Ryan L. (2000) Intelligence and physical features of children of women with epilepsy. Teratology 61:196202.
  • Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, Ryan LM. (2001) The teratogenicity of anticonvulsant drugs. N Engl J Med 344:11321138.
  • Holmes LB. (2002) The teratogenicity of anticonvulsant drugs: a progress report. J Med Genet 39:245247.
  • Holmes LB, Wyszynski DF, Lieberman E. (2004) The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 61:673678.
  • Holmes LB, Baldwin EJ, Smith CR, Habecker E, Glassman LH, Wong SL, Wyszynski DF. (2008) Increased risk frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 70:21522158.
  • Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. (2001) Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285:29812986.
  • Hunt S, Craig J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, Morrison PJ, Morrow J. (2006) Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 67:18761879.
  • Hunt S, Russell A, Smithson WH, Parsons L, Robertson I, Waddell R, Irwin B, Morrison PJ, Morrow J, Craig J; UK Epilepsy and Pregnancy Register (2008) Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 71:272276.
  • Hvas C, Henriksen T, Ostergaard J, Dam M. (2000) Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. Br J Obstet Gynaecol 107:896902.
  • Johannessen SI, Helde G, Brodtkorb E. (2005) Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia 46:775777.
  • Kaaja E, Kaaja R, Hiilesmaa V. (2003) Major malformations in offspring of women with epilepsy. Neurology 60:575579.
  • Kampman MT, Johansen SV, Stenvold H, Acharya G. (2005) Management of women with epilepsy: are guidelines being followed? Results from case-note reviews and a patient questionnaire. Epilepsia 46:12861292.
  • Kaplan PW, Norwitz ER, Ben Menachem E, Pennell PB, Druzin M, Robinson JN, Gordon JC. (2007) Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav 11:283291.
  • Kjaer D, Horvath-Puhó E, Christensen J, Vestergaard M, Czeizel AE, Sørensen HT, Olsen J. (2007) Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study. Pharmacoepidemiol Drug Saf 16:181188.
  • Koch S, Titze K, Zimmerman R, Schroder M, Lehmkuhl U, Rauh H. (1999) Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 40:12371243.
  • Koerner M, Yerby M, Friel P, McCormick K. (1989) Valproic acid disposition and protein binding in pregnancy. Ther Drug Monit 11:228230.
  • Kondo T, Kaneko S, Amano Y, Egawa I. (2004) Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epilepsia 37:12421244.
  • Krishnamurthy K, Sundstrom D, Beaudoin J, Kiriakopoulos E. (2002) Pregnant women with epilepsy taking older anticonvulsants must have drug levels checked frequently to avoid seizures. Epilepsia 43(Suppl. 7):232233.
  • Kuhnz W, Koch S, Jakob S, Hartmann A, Helge H, Nau H. (1984) Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status. Br J Clin Pharmacol, 18:671677.
  • Lander CM, Livingstone I, Tyrer JH, Eadie MJ. (1981) The clearance of anticonvulsant drugs in pregnancy. Clin Exp Neurol, 17:7178.
  • Leavitt A, Yerby M, Robinson N, Sells C, Erickson D. (1992) Epilepsy in pregnancy: developmental outcome of offspring at 12 months. Neurology 42(4 Suppl. 5):141143.
  • Leonard G, Andermann E, Ptito A. (1997) Cognitive effects of antiepileptic drug therapy during pregnancy on school-age offspring. Epilepsia 38(Suppl. 3):170 [Abstract].
  • Levy RH, Yerby MS. (1985) Effects of pregnancy on antiepileptic drug utilization. Epilepsia 26(Suppl. 1):5257.
  • Lin AE, Peller AJ, Westgate MN, Houde K, Franz A, Holmes LB. (2004) Clonazepam use in pregnancy and the risk of malformations. Birth Defects Res A Clin Mol Teratol 70:534536.
  • Lindhout D, Meinardi H, Meijer J, Nau H. (1992) Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology 42(Suppl. 5):94110.
  • Losche G, Steinhausen HC, Koch S, Helge H. (1994) The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors. Acta Paediatr 83:961966.
  • Matalon S, Schechtman S, Goldzweig G, Ornoy A. (2002) The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 16:917.
  • Mawer G, Clayton-Smith J, Coyle H, Kivity S. (2002) Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure 11:512518.
  • Mazzucchelli I, Onat FY, Ozkara C, Atakli D, Specchio LM, Neve AL, Gatti G, Perucca E. (2006) Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium. Epilepsia 47:504509.
  • Meador K. (2001) Cognitive effects of epilepsy and of antiepileptic medications. In WyllieE (Ed.) The treatment of epilepsy: principles and practice. 3rd ed. Williams and Wilkins, Philadelphia, pp. 12151226.
  • Meador KJ, Zupanc ML. (2004) Neurodevelopmental outcomes of children born to mothers with epilepsy. Cleve Clin J Med 71(Suppl. 2):S38S40.
  • Meador KJ, Baker GA, Finnell RH, Kalayjian LA, Liporace JD, Loring DW, Mawer G, Pennell PB, Smith JC, Wolff MC. (2006) In utero antiepileptic drug exposure: fetal death and malformations. Neurology 67:407412.
  • Meador KJ, Browning N, Cohen MJ, Kalaygian L, Liporace J, Pennell PB, Privitera M, Kanner A, Cantrell D. (2007) In utero antiepileptic drugs: differential cognitive outcomes in children of women with epilepsy. Neurology 68(Suppl. 1):A337.
  • Meador KJ, Pennell PB, Harden CL, Gordon JC, Tomson T, Kaplan PW, Holmes GL, French JA, Hauser WA, Wells PW, Cramer JA, HOPE Work Group. (2008) Pregnancy registries in epilepsy: a consensus statement on health outcomes. Neurology 71:11091117.
  • Meischenguiser R, D’Giano CH, Ferraro SM. (2004) Oxcarbazepine in pregnancy: clinical experience in Argentina. Epilepsy Behav 5:163167.
  • Minkoff H, Schaffer R, Delke I, Grunevaum A. (1985) Diagnosis of intracranial hemorrhage in utero after a maternal seizure. Obstet Gynecol 65(Suppl.):22S24S.
  • Montouris G. (2003) Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 4:310317.
  • Moore K. (1988) The developing human: clinically oriented embryology. 4th ed. WB Saunders, Philadelphia.
  • Morrell M. (1998) Guidelines for the care of women with epilepsy. Neurology 51(Suppl. 5):S21S27.
  • Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J. (2006) Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77:193198.
  • MRC Vitamin Study Research Group. (1991) Prevention of neural-tube defects: results of the Medical Research Council Vitamin Study. Lancet, 338:131137.
  • Nambisan M, Wyszynski DF, Holmes LB. (2003) No evidence of a protective effect due to periconceptional folic acid (PCFA) intake on risk for congenital anomalies in the offspring of mothers exposed to antiepileptic drugs (AEDs). Birth Defects Res A Clin Mol Teratol 67:5.
  • Nei M, Daly S, Liporace J. (1998) A maternal complex partial seizure in labor can affect fetal heart rate. Neurology 51:904906.
  • Newport DJ, Pennell PB, Calamaras MR, Ritchie JC, Newman M, Knight B, Viguera AC, Liporace J, Stowe ZN (2008) Lamotrigine in breast milk and nursing infants: determination of exposure. Pediatrics 122:e223e231.
  • Oguni M, Dansky L, Andermann E, Sherwin A, Andermann F. (1992) Improved pregnancy outcome in epileptic women in the last decade: relationship to maternal anticonvulsant therapy. Brain Dev 14:371380.
  • Ohman I, Vitols S, Tomson T. (2000) Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 41:709713.
  • Olafsson E, Hallgrimsson JT, Hauser WA, Ludvigsson P, Gudmundsson G. (1998) Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 39:887892.
  • Omtzigt JG, Los FJ, Grobbee DE, Pijpers L, Jahoda MG, Brandenburg H, Stewart PA, Gaillard HL, Sachs ES, Wladimiroff JW. (1992) The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 42(4 Suppl. 5):119125.
  • Pearlman M, Tintinalli J, Lorenz R. (1990) Blunt trauma during pregnancy. N Engl J Med, 323:16091613.
  • Pennell PB. (2003) Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 61(6 Suppl. 2):S35S42.
  • Pennell PB, Newport DJ, Stowe ZN, Helmers SL, Montgomery JQ, Henry TR. (2004) The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 62:292295.
  • Pennell PB. (2005) Using current evidence in selecting antiepileptic drugs for use during pregnancy. Epilepsy Curr 5:4551.
  • Pennell PB. (2006) Is breast milk the best for babies of mothers on levetiracetam? Epilepsy Curr 6:2224.
  • Pennell PB, Gidal BE, Sabers A, Gordon J, Perucca E. (2007a) Pharmacology of antiepileptic drugs during pregnancy and lactation. Epilepsy Behav 11:263269.
  • Pennell PB, Peng L, Newport DJ, Ritchie JR, Koganti A, Holley DK, Newman M, Stowe ZN (2007b) Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 70:21302136.
  • Pennell PB. (2008) Antiepileptic drug pharmacokinetics in pregnancy. In GidalBE, HardenCL (Eds) Epilepsy in women: scientific basis for practical management. Elsevier, New York, pp. 227–240.
  • Perucca E, Crema A. (1982) Plasma protein binding of drugs in pregnancy. Clin Pharmacokinet 7:336352.
  • Petrenaite V, Sabers A, Hansen-Schwartz J. (2005) Individual changes in lamotrigine plasma concentrations during pregnancy. Epilepsy Res 65:185188.
  • Puho EH, Szunyogh M, Metneki J, Czeizel AE. (2007) Drug treatment during pregnancy and isolated orofacial clefts in Hungary. Cleft Palate Craniofac J 44:194202.
  • Rating D, Nau H, Jager-Roman E, Gopfert-Geye I, Koch S, Beck-Mannagetta G, Schmidt D, Helge H. (1982) Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women. Acta Paediatr Scand 71:301311.
  • Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. (1995) In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274:15181525.
  • Report of the Quality Standards Subcommittee of the American Academy of Neurology. (1998) Practice parameter: management issues for women with epilepsy (summary statement). Neurology, 51:944948.
  • Rosa F. (1991) Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 324:674677.
  • Sabers A, Dam M, Rogvi-Hansen B, Boas J, Sidenius P, Laue FM, Alving J, Dahl M, Ankerhus J, Mouritzen DA. (2004) Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand 109:913.
  • Samrén E, Van Duijn C, Koch S, Hiilesmaa VK, Klepel H, Bardy AH, Mannagetta GB, Deichi AW, Gaily E, Granstrom ML, Meinardi H, Grobbee DE, Hofman A, Janz D, Lindhout D. (1997) Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 38:981990.
  • Samrén E, Van Duijn C, Christiaens G, Hofman A, Lindhout D. (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46:739746.
  • Sankar R. (2007) Teratogenicity of antiepileptic drugs: role of drug metabolism and pharmacogenomics. Acta Neurol Scand 116:6571.
  • Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, Gardner HA, Gladstone R, Ashby P, Weksberg R, Einarson T. (1994) Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271:767770.
  • Stumpf D, Frost M. (1978) Seizures, anticonvulsants, and pregnancy. Am J Dis Child 132:746748.
  • Teramo K, Hiilesmaa V, Bardy A, Saarikoski S. (1979) Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med 7:35.
  • Teramo K, Hiilesmaa V. (1982) Pregnancy and fetal complications in epileptic pregnancies: review of the literature. In JanzD, DamM, RichensA, BossiL, HelgeH, SchmidtD (Eds) Epilepsy, pregnancy and the child. Raven Press, New York, pp. 5359.
  • The EURAP Study Group. (2006) Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 66:354360.
  • Thomas SV, Ajaykumar B, Sindhu K, Nair MK, George B, Sarma PS. (2008) Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 13:229236.
  • Tomson T, Lindbom U, Hasselstrom J. (1990) Plasma concentrations of ethosuximide and clonazepam during pregnancy. J Epilepsy 3:9195.
  • Tomson T, Lindbom U, Ekqvist B, Sundqvist A. (1994) Disposition of carbamazepine and phenytoin in pregnancy. Epilepsia 35:131135.
  • Tomson T, Battino D. (2007) Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 46:209219.
  • Tomson T, Palm R, Kallen K, Ben Menachem E, Soderfeldt B, Danielsson B, Johansson R, Luef G, Ohman I. (2007) Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia 48:11111116.
  • Tran T, Leppik I, Blesi K, Sathanandan S, Remmel R. (2002) Lamotrigine clearance during pregnancy. Epilepsia 59:251255.
  • Vajda FJ, O’Brien TJ, Hitchcoc A, Graham J, Lander C. (2003) The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months. J Clin Neurosci 10:543549.
  • Vajda FJ, O’Brien TJ, Hitchcock A, Graham J, Cook M, Lander C, Eadie MJ. (2004) Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 11:854858.
  • Vajda FJ, Eadie MJ. (2005) Maternal valproate dosage and foetal malformations. Acta Neurol Scand 112:137143.
  • Vajda FJ, Hitchcock A, Graham J, Solinas C, O’Brien TJ, Lander CM, Eadie MJ. (2006) Fetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol 13:645654.
  • Vanoverloop D, Schnell RR, Harvey EA, Holmes LB. (1992) The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol 14:329335.
  • Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA. (2005) Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64:949954.
  • Wide K, Henning E, Tomson T, Winbladh B. (2002) Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 91:409414.
  • Wide K, Winbladh B, Kallen B. (2004) Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 93:174176.
  • Wikner BN, Stiller CO, Bergman U, Asker C, Källén B. (2007) Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf 16:12031210.
  • Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. (2005) Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64:961965.
  • Yerby MS, Friel PN, Miller DQ. (1985) Carbamazepine protein binding and disposition in pregnancy. Ther Drug Monit 7:269273.
  • Yerby MS, Friel PN, McCormick K, Koerner M, Van Allen M, Leavitt AM, Sells CJ, Yerby JA. (1990) Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Res 5:223228.
  • Yerby MS, Friel PN, McCormick K. (1992) Antiepileptic drug disposition during pregnancy. Neurology 42(4 Suppl. 5):1216.
  • Yerby M, Devinsky O. (1994) Epilepsy and pregnancy. In DevinskyO, FeldmannE, HainlineB (Eds) Advances in neurology: neurological complications of pregnancy. Vol. 64. Raven Press, New York, pp. 4563.
  • Yerby M, Cawthon M. (1996) Fetal death, malformations and infant mortality in infants of mothers with epilepsy. Epilepsia 37(Suppl. 5):98.
  • Yerby M, Collins S. (1997a) Pregnancy and the mother. In EngelJ, PedleyT (Eds) Epilepsy, a comprehensive textbook. Lippincott-Raven, Philadelphia, pp. 20272035.
  • Yerby M, Collins S. (1997b) Teratogenicity of antiepileptic drugs. In EngelJ, PedleyT (Eds) Epilepsy, a comprehensive textbook. Lippincott-Raven, Philadelphia, pp. 11951203.
  • Yerby MS. (2000) Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology 55:2131.
  • Yerby MS. (2003) Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia 44:3340.
  • Zahn CA, Morrell MJ, Collins SD, Labiner DM, Yerby MS. (1998) Management issues for women with epilepsy: a review of the literature. Neurology 51:949956.